Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Lepper, Alisa [VerfasserIn]   i
 Weber, Rebekka [VerfasserIn]   i
 Özbay Kurt, Feyza Gül [VerfasserIn]   i
 Arkhypov, Ihor [VerfasserIn]   i
 Lasser, Samantha [VerfasserIn]   i
 Utikal, Jochen [VerfasserIn]   i
 Umansky, Viktor [VerfasserIn]   i
Titel:Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
Titelzusatz:original research
Verf.angabe:Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Utikal, and Viktor Umansky
E-Jahr:2023
Jahr:13 Aug 2023
Umfang:9 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 16.04.2024
Titel Quelle:Enthalten in: OncoImmunology
Ort Quelle:Abingdon : Taylor & Franics, 2012
Jahr Quelle:2023
Band/Heft Quelle:12(2023), 1, Seite 1-9
ISSN Quelle:2162-402X
Abstract:Treatment with immune checkpoint inhibitors (ICIs) has improved the prognosis of melanoma patients. However, ICIs can cause an overactivation of the immune system followed by diverse immunological side effects known as immune-related adverse events (irAE). Currently, the toxicity of irAE is limiting the usage of ICIs. Here, we studied circulating monocytic myeloid-derived suppressor cells (M-MDSCs) and T cells in course of irAE after the ICI therapy. Our longitudinal study involved 31 melanoma patients with and without adverse events during anti-PD-1 monotherapy or anti-CTLA-4/PD-1 combination therapy. Peripheral blood samples were analyzed before ICI start, during ICI treatment, at the time point of irAE and during immunosuppressive treatment to cure irAE. We observed an enhanced progression-free survival among patients with irAE. In patients with irAE, we found an upregulation of CD69 on CD8+ T cells and a decreased frequency of regulatory T cells (Tregs). Moreover, lower frequencies of Tregs correlated with more severe side effects. Patients treated with immunomodulatory drugs after irAE manifestation tend to show an elevated number of M-MDSCs during an immunosuppressive therapy. We suggest that an activation of CD8+ T cells and the reduction of Treg frequencies could be responsible for the development of irAE.
DOI:doi:10.1080/2162402X.2023.2247303
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1080/2162402X.2023.2247303
 kostenfrei: Volltext: https://www.tandfonline.com/doi/full/10.1080/2162402X.2023.2247303
 DOI: https://doi.org/10.1080/2162402X.2023.2247303
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Immune-related adverse events
 immunotherapy
 melanoma
K10plus-PPN:1885917082
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69204678   QR-Code
zum Seitenanfang